# Brooke Rollins

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/brooke-rollins
Canonical HTML page: https://getbiobrief.com/entity/brooke-rollins

## Recent coverage (1 stories)

### Trump's 3rd-Choice FDA Pick Overton Shifts Pharma's Regulatory Outlook
2026-08-19 18:17:37 · Sentiment: Neutral · Impact: 7/10 · Sources: 2

Biopharma's key regulator is set to change hands as Trump nominates Heidi Overton, architect of drug-pricing negotiations and vaccine-schedule revisions. Developers and investors are assessing what her confirmation means for approval timelines, pricing pressure, and regulatory predictability.
Full story: https://getbiobrief.com/story/heidi-overton-fda-pharma-regulatory-outlook-bio

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.